Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12–49. https://doi.org/10.3322/caac.21830.

Article  PubMed  Google Scholar 

McCurdy A, Seow H, Pond GP, Gayowsky A, Chakraborty R, Visram A, et al. Cancer-specific mortality in multiple myeloma: a population-based retrospective cohort study. Haematologica. 2023;108(12):3384–91. https://doi.org/10.3324/haematol.2023.282905.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Usui Y, Ito H, Koyanagi Y, Shibata A, Matsuda T, Katanoda K, et al. Changing trend in mortality rate of multiple myeloma after introduction of novel agents: a population-based study. Int J Cancer. 2020;147(11):3102–9. https://doi.org/10.1002/ijc.33135.

Article  CAS  PubMed  Google Scholar 

Jew S, Bujarski S, Regidor B, Emamy-Sadr M, Swift R, Eades B, et al. Clinical outcomes and serum B-cell maturation antigen levels in a real-world unselected population of newly diagnosed multiple myeloma patients. Target Oncol. 2023;18(5):735–47. https://doi.org/10.1007/s11523-023-00990-6.

Article  PubMed  Google Scholar 

Mohty M, Knauf W, Romanus D, Corman S, Verleger K, Kwon Y, et al. Real-world treatment patterns and outcomes in non-transplant newly diagnosed multiple myeloma in France, Germany, Italy, and the United Kingdom. Eur J Haematol. 2020;105(3):308–25. https://doi.org/10.1111/ejh.13439.

Article  PubMed  PubMed Central  Google Scholar 

Joseph NS, Kaufman JL, Dhodapkar MV, Hofmeister CC, Almaula DK, et al. Long-term follow-up results of lenalidomide, bortezomib, and dexamethasone induction therapy and risk-adapted maintenance approach in newly diagnosed multiple myeloma. J Clin Oncol. 2020;38(17):1928–37. https://doi.org/10.1200/JCO.19.02515.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Attal M, Lauwers-Cances V, Hulin C, Leleu X, Caillot D, Escoffre M, et al. Lenalidomide, bortezomib, and dexamethasone with transplantation for myeloma. N Engl J Med. 2017;376(14):1311–20. https://doi.org/10.1056/NEJMoa1611750.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Richardson PG, Jacobus SJ, Weller EA, Hassoun H, Lonial S, Raje NS, et al. Triplet therapy, transplantation, and maintenance until progression in myeloma. N Engl J Med. 2022;387(2):132–47. https://doi.org/10.1056/NEJMoa2204925.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Binder M, Nandakumar B, Rajkumar SV, Kapoor P, Buadi FK, Dingli D, et al. Mortality trends in multiple myeloma after the introduction of novel therapies in the United States. Leukemia. 2022;36(3):801–8. https://doi.org/10.1038/s41375-021-01453-5.

Article  PubMed  Google Scholar 

Chacon A, Leleu X, Bobin A. 30 years of improved survival in non-transplant-eligible newly diagnosed multiple myeloma. Cancers. 2023;15(7):1–12. https://doi.org/10.3390/cancers15071929.

Article  CAS  Google Scholar 

Pinto V, Bergantim R, Caires HR, Seca H, Guimarães JE, Vasconcelos MH. Multiple myeloma: available therapies and causes of drug resistance. Cancers (Basel). 2020;12(3):1–32. https://doi.org/10.3390/cancers12020407.

Article  CAS  Google Scholar 

Holland JF, Hosley H, Scharlau C, Carbone PP, Frei E, Brindley CO, et al. A controlled trial of urethane treatment in multiple myeloma. Blood. 1966;27(3):328–42.

CAS  PubMed  Google Scholar 

Russell BM, Avigan DE. Immune dysregulation in multiple myeloma: the current and future role of cell-based immunotherapy. Int J Hematol. 2023;117:652–9. https://doi.org/10.1007/s12185-023-03579-x.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rajkumar SV. Updated diagnostic criteria and staging system for multiple myeloma. ASCO Educ Book. 2016;35:36–23. https://doi.org/10.14694/EDBK_159009.

Article  Google Scholar 

Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos MV, et al. Review International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. J Clin Oncol. 2014;15(12):538–48. https://doi.org/10.1200/JCO.2014.59.1636.

Article  CAS  Google Scholar 

Padala SA, Barsouk A, Barsouk A, Rawla P, Vakiti A, Kolhe R, et al. Epidemiology, staging, and management of multiple myeloma. Med Sci. 2021;9(1):1–14. https://doi.org/10.3390/medsci9010003.

Article  CAS  Google Scholar 

Berenson A, Vardanyan S, David M, Wang J, Harutyunyan NM, Gottlieb J, et al. Improved clinical outcomes for multiple myeloma patients treated at a single specialty clinic. Ann Hematol. 2017;96(3):441–8. https://doi.org/10.1007/s00277-016-2888-3.

Article  CAS  PubMed  Google Scholar 

Blimark CH, Vangsted AJ, Klausen TW, Gregersen H, Szabo AG, Hermansen E, et al. Outcome data from > 10,000 multiple myeloma patients in the Danish and Swedish national registries. Eur J Haematol. 2022;108(2):99–108. https://doi.org/10.1111/ejh.13707.

Article  PubMed  Google Scholar 

Möller MD, Gengenbach L, Graziani G, Greil C, Wäsch R, Engelhardt M. Geriatric assessments and frailty scores in multiple myeloma patients: a needed tool for individualized treatment? Curr Opin Oncol. 2021;33(6):648–57. https://doi.org/10.1097/CCO.0000000000000792.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Engelhardt M, Ihorst G, Duque-Afonso J, Wedding U, Spät-Schwalbe E, Goede V, et al. Structured assessment of frailty in multiple myeloma as a paradigm of individualized treatment algorithms in cancer patients at advanced age. Haematologica. 2020;105(5):1183–8. https://doi.org/10.3324/haematol.2019.242958.

Article  PubMed  PubMed Central  Google Scholar 

Mian H, Wildes TM, Vij R, Pianko MJ, Major A, Fiala MA. Dynamic frailty risk assessment among older adults with multiple myeloma: a population-based cohort study. Blood Cancer J. 2023;13(1):76. https://doi.org/10.1038/s41408-023-00843-5.

Article  PubMed  PubMed Central  Google Scholar 

Cook MB, McGlynn KA, Devesa SS, Freedman ND, Anderson WF. Sex disparities in cancer mortality and survival. Cancer Epidemiol Biomark Prev. 2011;20(8):1629–37. https://doi.org/10.1158/1055-9965.EPI-11-0246.

Article  Google Scholar 

Derman BA, Langerman SS, Maric M, Jakubowiak A, Zhang W, Chiu BCH. Sex differences in outcomes in multiple myeloma. Br J Haematol. 2021;192(3):66–9. https://doi.org/10.1111/bjh.17237.

Article  Google Scholar 

Bird S, Cairns D, Menzies T, Boyd K, Davies F, Cook G, et al. Sex differences in multiple myeloma biology but not clinical outcomes: results from 3894 patients in the Myeloma XI trial. Clin Lymphoma Myeloma Leuk. 2021;21(10):667–75. https://doi.org/10.1016/j.clml.2021.04.013.

Article  PubMed  PubMed Central  Google Scholar 

Sun RS, Sui JF, Chen XH, Ran XZ, Yang ZF, Da Guan W, et al. Detection of CD4 +CD25 +FOXP3 + regulatory T cells in peripheral blood of patients with chronic autoimmune urticaria. Australas J Dermatol. 2010;52(3):15–8. https://doi.org/10.1111/j.1440-0960.2010.00658.x.

Article  Google Scholar 

Muthu Raja KR, Rihova L, Zahradova L, Klincova M, Penka M, Hajek R. Increased T regulatory cells are associated with adverse clinical features and predict progression in multiple myeloma. PLoS ONE. 2012;7(10):1–11. https://doi.org/10.1371/journal.pone.0047077.

Article  CAS  Google Scholar 

Derman BA, Zha Y, Zimmerman TM, Malloy R, Jakubowiak A, Bishop MR, et al. Regulatory T-cell depletion in the setting of autologous stem cell transplantation for multiple myeloma: pilot study. J Immunother Cancer. 2020;8(1):1–9. https://doi.org/10.1136/jitc-2019-000286.

Article  Google Scholar 

de Magalhães RJP, Vidriales MB, Paiva B, Fernandez-Gimenez C, García-Sanz R, Mateos MV, et al. Analysis of the immune system of multiple myeloma patients achieving long-term disease control by multidimensional flow cytometry. Haematologica. 2013;98(1):79–86. https://doi.org/10.3324/haematol.2012.067272.

Article  Google Scholar 

Schmikla H, de la Mora M, Davis JJ, Montanez LB, Madden EM. Stem cell transplant minimizes insurance coverage-driven outcome disparities for multiple myeloma patients. Biol Blood Marrow Transplant. 2020;26(3):546.

Google Scholar 

Bhatt VR, Loberiza FR, Schmit-Pokorny K, Lee SJ. Time to insurance approval in private and public payers does not influence survival in patients who undergo hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2016;22(6):1117–24. https://doi.org/10.1016/j.bbmt.2016.03.008.

Article  PubMed